Author | Kerry Rogers, MD | OncLive

Author | Kerry Rogers, MD

Articles

Dr. Rogers on Data for Ibrutinib in Hairy Cell Leukemia

October 25, 2019

Video

Kerry Rogers, MD, discusses the results from an ongoing phase II trial investigating ibrutinib in patients with relapsed/refractory hairy cell leukemia. Because this represents a very rare patient population, accrual began in 2013, and these data reflect on a small portion of the 39 patients enrolled.

Dr. Rogers on Reducing Risk of Tumor Lysis Syndrome in CLL

July 26, 2018

Video

Kerry Rogers, MD, assistant professor, Internal Medicine, Division of Hematology, The Ohio State University Comprehensive Cancer Center, discusses reducing the risk of tumor lysis syndrome during the treatment of patients with chronic lymphocytic leukemia.

Dr. Rogers on Benefits of Ibrutinib Combination in CLL

February 01, 2018

Video

Kerry Rogers, MD, assistant professor, Internal Medicine, Division of Hematology, The Ohio State University Comprehensive Cancer Center, discusses the benefits of ibrutinib (Imbruvica) in combination with venetoclax (Venclexta) and obinutuzumab (Gazyva) for patients with chronic lymphocytic leukemia (CLL).

Dr. Rogers on Determining Patients With High-Risk CLL

January 18, 2018

Video

Kerry Rogers, MD, assistant professor, Internal Medicine, Division of Hematology, The Ohio State University Comprehensive Cancer Center, discusses how to determine patients with high-risk chronic lymphocytic leukemia (CLL).

x